OSBPL3 and metabolic dysfunction-associated steatohepatitis: OSBPL3, whose mRNA was hypermethylated with 18-fold change and upregulated with seven-fold change in HFD mice livers, has been reported to be closely associated with the progress of hepatic inflammation in advanced stages of NASH (Stein et al., 2017).